Asymptomatic brain metastases incidentally diagnosed in about 4% of patients with mRCC during clinical trial screening
History of VTE predicts VTE occurrence; VTE occurrence linked to increased mortality
Local surgery or ablation may be most appropriate for patients with a solitary site of locoregional recurrence following definitive surgery for clinically localized renal cell carcinoma, according to investigators.
Investigators report findings from the phase 3 CLEAR trial that assessed outcomes with pembrolizumab plus lenvatinib, lenvatinib plus everolimus, or sunitinib in treatment-naive patients with advanced renal cell carcinoma.
Cutaneous immune-related adverse events seen in 25% of cancer patients initiating ICI therapy with median onset time of 113 days
A study of the effect of renal hypothermia during partial nephrectomy should have an immediate impact on surgical practice, according to investigators.
Study findings corroborate previous research linking higher income with increased healthcare utilization.
A study was conducted to assess factors contributing to response to nivolumab treatment for advanced clear cell renal cell carcinoma.
Risk for death lower for patients with lung cancer, renal cell carcinoma, melanoma with versus without obesity
Fotivda is an oral vascular endothelial growth factor tyrosine kinase inhibitor.